Showing results (311-320 of 358) with videos related to
Sort By:
Pageof 36
BMC Primary Care|January 25, 2025
Ten pressure points in primary care during COVID-19: findings from an international narrative reviewSally Hall Dykgraaf, Anne Parkinson, Michael Wright, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 17, 2020
Perioperative Outcomes of Robotic Pancreaticoduodenectomy: a Propensity-Matched Analysis to Open and Laparoscopic PancreaticoduodenectomyA Floortje van Oosten, Ding Ding, Joseph R Habib, et al.Environment International|July 13, 2019
Development of outcome-specific criteria for study evaluation in systematic reviews of epidemiology studiesElizabeth G Radke, Barbara Glenn, Audrey Galizia, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 9, 2020
Defining a minimum number of examined lymph nodes improves the prognostic value of lymphadenectomy in pancreas ductal adenocarcinomaNing Pu, Shanshan Gao, Ross Beckman, et al.Bioanalysis|July 29, 2022
Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategyKyra J Cowan, Michaela Golob, Joanne Goodman, et al.Bioorganic & Medicinal Chemistry Letters|October 28, 2011
Discovery of N-aryl-2-acylindole human glucagon receptor antagonistsChristopher Sinz, Amy Bittner, Ed Brady, et al.Chinese Clinical Oncology|June 25, 2020
Radical antegrade modular pancreatosplenectomy versus standard distal pancreatosplenectomy for pancreatic cancer, a dual-institutional analysisJonathan G Sham, Shiwei Guo, Ding Ding, et al.Nature Genetics|May 10, 2011
Mutations in CEP57 cause mosaic variegated aneuploidy syndromeKatie Snape, Sandra Hanks, Elise Ruark, et al.Scientific Reports|January 31, 2017
Discovery of a junctional epitope antibody that stabilizes IL-6 and gp80 protein:protein interaction and modulates its downstream signalingRalph Adams, Rebecca J Burnley, Chiara R Valenzano, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2011
Discovery of cyclic guanidines as potent, orally active, human glucagon receptor antagonistsChristopher Sinz, Jiang Chang, Ashley Rouse Lins, et al.Pageof 36